Skip to main content

Table 5 Costs, effects and cost-effectiveness of interventions analyzed

From: Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina

Intervention

Total Cost per year (ARS$) (1)

DALY Age weighted, 3% discounted per year (2)

DALY No age-weight 3% discounted per year

DALY # age-weight, undiscounted per year

ARS$ (1)/DALY (2)

Less salt in bread

$ 87,471

579

713

1,107

$ 151

Mass media campaign

$ 634,069

1,158

1,426

2,213

$ 547

Combined therapy 20% global CV risk

$ 23,533,467

6,539

8,033

12,468

$ 3,599

Combined therapy 10% global CV risk

$ 46,323,335

11,263

13,913

2,163

$ 4,113

Combined therapy 5% global CV risk

$ 63,893,600

14,095

17,409

2,706

$ 4,533

HBP lowering therapy

$ 37,478,853

4,857

5,919

9,185

$ 7,716

Tobacco cessation therapy with bupropion

$ 12,317,628

367

449

697

$ 33,563

High-chol lowering with statins

$ 40,253,626

567

712

1,087

$ 70,994